ECSP003419A - THERAPY FOR MELANOMAS - Google Patents
THERAPY FOR MELANOMASInfo
- Publication number
- ECSP003419A ECSP003419A ECSP003419A ECSP003419A EC SP003419 A ECSP003419 A EC SP003419A EC SP003419 A ECSP003419 A EC SP003419A EC SP003419 A ECSP003419 A EC SP003419A
- Authority
- EC
- Ecuador
- Prior art keywords
- treatment
- well
- pegylated interferon
- therapy
- melanomas
- Prior art date
Links
- 201000001441 melanoma Diseases 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 108010047761 Interferon-alpha Proteins 0.000 abstract 1
- 102000006992 Interferon-alpha Human genes 0.000 abstract 1
- 238000009098 adjuvant therapy Methods 0.000 abstract 1
- -1 for example Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108010092851 peginterferon alfa-2b Proteins 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describen métodos para tratar pacientes nuevos al tratamiento, así como también pacientes con experiencia en el tratamiento, que tienen melanoma, para incrementar el tiempo de supervivencia libre de progresión que involucra la administración de una cantidad terapéuticamente eficaz de interferon-alfa pegilado, por ejemplo, interferon alfa-2b pegilado, asi como también terapia coadyuvante para cirugia definitiva.Methods of treating patients new to treatment, as well as treatment-experienced patients, who have melanoma, are described to increase progression-free survival time involving administration of a therapeutically effective amount of pegylated interferon-alpha, for example , pegylated interferon alfa-2b, as well as adjuvant therapy for definitive surgery.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003419 ECSP003419A (en) | 2000-04-06 | 2000-04-06 | THERAPY FOR MELANOMAS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003419 ECSP003419A (en) | 2000-04-06 | 2000-04-06 | THERAPY FOR MELANOMAS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003419A true ECSP003419A (en) | 2000-11-24 |
Family
ID=42041048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003419 ECSP003419A (en) | 2000-04-06 | 2000-04-06 | THERAPY FOR MELANOMAS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003419A (en) |
-
2000
- 2000-04-06 EC ECSP003419 patent/ECSP003419A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1173178E (en) | COMPOSITION UNDERSTANDING APOMORPHINE AND SILDENAFIL AND USES THEMSELVES FOR THE TREATMENT OF ERECTILE DISFUNCTION | |
| AR021226A1 (en) | COMBINATORY THERAPY WITH RIBAVIRINA-INTERFERON ALFA TO ERADICATE DETECTABLE HCV-RNA IN THOSE PATIENTS WHO PRESENT INFECTION WITH CHRONIC HEPATITIS C | |
| BR9911076A (en) | Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis C | |
| MY127290A (en) | New use of flibanserin | |
| MY155270A (en) | Use of glp-1 or analogs in treatment of stroke | |
| DK0998287T3 (en) | Use of levobupivacaine | |
| ATE332136T1 (en) | AGENTS SUCH AS NICOTINAMIDE OR CADPR FOR THE TREATMENT OF SKIN DISEASES | |
| NO20072543L (en) | Anti-cancer treatment | |
| BR0211932A (en) | Methods and compositions for oral administration of parathyroid hormone, pth | |
| ATE356631T1 (en) | ORAL ADMINISTRATION OF PARATHYROID HORMONE AND CALCITONIN | |
| JP2003528919A5 (en) | ||
| TW200511999A (en) | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone | |
| PT1220676E (en) | PREVENTION OF COLORCECTAL CANCER | |
| ATE297732T1 (en) | COMBINATION THERAPY FOR THE TREATMENT OF HEART FAILURE | |
| MXPA04001912A (en) | Novel aminobenzoephenones. | |
| BR0108261A (en) | Use of mirtazapine, method of treating a sleep disorder in an individual, and patient kit for the treatment of sleep disorders | |
| AR023398A1 (en) | MELANOMAS THERAPY | |
| ATE330600T1 (en) | COMBINATION PREPARATION FOR CANCER THERAPY | |
| CO5160259A1 (en) | INTERFERON ALFA PEGILADO IN THE THERAPY AGAINST HIV | |
| ATE345805T1 (en) | CALCIUM TRIFLUOROCETATE WITH CYTOTOXIC EFFECT | |
| GB9827121D0 (en) | Agent for lowering endothelin levels | |
| BR0311141A (en) | Synergistically interaction of abacavir and alovudine | |
| AR025711A1 (en) | THE USE OF DESLORATADINE FOR THE PREPARATION OF A MEDICINAL PRODUCT TO TREAT AND PREVENT ALLERGIC AND INFLAMMATORY STATES | |
| ECSP003373A (en) | HIV THERAPY | |
| MD1469F1 (en) | Method of treatment of the burn shock |